Virginia Reverte1, Venkateswara R Gogulamudi1, Carla B Rosales1, Diego C Musial2, Sabrina R Gonsalez3, Alberto J Parra-Vitela1, Michelle Galeas-Pena1, Venkata N Sure4, Bruna Visniauskas1, Sarah H Lindsey4, Prasad V G Katakam4, Minolfa C Prieto5. 1. Department of Physiology, Tulane University School of Medicine, New Orleans, USA. 2. Department of Physiology, Tulane University School of Medicine, New Orleans, USA; Department of Pharmacology, Universidade Federal de Sao Paulo, Sao Paulo, Brazil. 3. Department of Physiology, Tulane University School of Medicine, New Orleans, USA; Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil. 4. Department of Pharmacology, Tulane University School of Medicine, New Orleans, USA. 5. Department of Physiology, Tulane University School of Medicine, New Orleans, USA; Hypertension and Renal Center of Excellence, New Orleans, USA. Electronic address: mprieto@tulane.edu.
Abstract
AIM OF THE STUDY: During type 2 diabetes (T2D) and hypertension there is stimulation of renal proximal tubule angiotensinogen (AGT), but whether urinary excretion of AGT (uAGT) is an indicator of glomerular damage or intrarenal RAS activation is unclear. We tested the hypothesis that elevations in uAGT can be detected in the absence of albuminuria in a mouse model of T2D. METHODS: Male C57BL/6 mice (N = 10) were fed a high fat (HFD; 45% Kcal from fat) for 28 weeks, and the metabolic phenotype including body weight, blood pressures, glucose, insulin, ippGTT, HOMA-IR, and cholesterol was examined. In addition, kidney Ang II content and reactive oxygen species (ROS) was measured along with urinary albumin, creatinine, Ang II, and AGT. RESULTS: All parameters consistent with T2D were present in mice after 12-14 weeks on the HFD. Systolic BP increased after 18 weeks in HFD but not NFD mice. Intrarenal ROS and Ang II concentrations were also increased in HFD mice. Remarkably, these changes paralleled the augmentation uAGT excretion (3.66 ± 0.50 vs. 0.92 ± 0.13 ng/mg by week 29; P < 0.01), which occurred in the absence of overt albuminuria. CONCLUSIONS: In HFD-induced T2D mice, increases in uAGT occur in the absence of overt renal injury, indicating that this biomarker accurately detects early intrarenal RAS activation.
AIM OF THE STUDY: During type 2 diabetes (T2D) and hypertension there is stimulation of renal proximal tubule angiotensinogen (AGT), but whether urinary excretion of AGT (uAGT) is an indicator of glomerular damage or intrarenal RAS activation is unclear. We tested the hypothesis that elevations in uAGT can be detected in the absence of albuminuria in a mouse model of T2D. METHODS: Male C57BL/6 mice (N = 10) were fed a high fat (HFD; 45% Kcal from fat) for 28 weeks, and the metabolic phenotype including body weight, blood pressures, glucose, insulin, ippGTT, HOMA-IR, and cholesterol was examined. In addition, kidney Ang II content and reactive oxygen species (ROS) was measured along with urinary albumin, creatinine, Ang II, and AGT. RESULTS: All parameters consistent with T2D were present in mice after 12-14 weeks on the HFD. Systolic BP increased after 18 weeks in HFD but not NFD mice. Intrarenal ROS and Ang II concentrations were also increased in HFD mice. Remarkably, these changes paralleled the augmentation uAGT excretion (3.66 ± 0.50 vs. 0.92 ± 0.13 ng/mg by week 29; P < 0.01), which occurred in the absence of overt albuminuria. CONCLUSIONS: In HFD-induced T2D mice, increases in uAGT occur in the absence of overt renal injury, indicating that this biomarker accurately detects early intrarenal RAS activation.
Authors: T Cooper Woods; Ryousuke Satou; Kayoko Miyata; Akemi Katsurada; Courtney M Dugas; Natasha C Klingenberg; Vivian A Fonseca; L Gabriel Navar Journal: Am J Nephrol Date: 2019-03-28 Impact factor: 3.754
Authors: Prasad V G Katakam; Angellica O Gordon; Venkata N L R Sure; I Rutkai; David W Busija Journal: Am J Physiol Heart Circ Physiol Date: 2014-08-15 Impact factor: 4.733
Authors: Shoujin Hao; Joseph Salzo; Hong Zhao; Mary Hao; Zbigniew Darzynkiewicz; Nicholas R Ferreri Journal: Hypertension Date: 2020-11-02 Impact factor: 10.190
Authors: Aarón Guerrero; Bruna Visniauskas; Pilar Cárdenas; Stefanny M Figueroa; Jorge Vivanco; Nicolas Salinas-Parra; Patricio Araos; Quynh My Nguyen; Modar Kassan; Cristián A Amador; Minolfa C Prieto; Alexis A Gonzalez Journal: Front Cardiovasc Med Date: 2021-06-04
Authors: Virginia Reverte; Francisca Rodriguez; Lidia Oltra; Juan M Moreno; María T Llinás; Courtney M Shea; Chad D Schwartzkopf; Emmanuel S Buys; Jaime L Masferrer; F Javier Salazar Journal: Am J Physiol Heart Circ Physiol Date: 2022-02-04 Impact factor: 4.733